MPD: Phenotype measures mapped to MP:0002062, abnormal associative learning

Phenotype measures associated with ontology term
MP:0002062 'abnormal associative learning'

This list includes measures mapped MP:0002062 AND its ontology descendants. Alternatively, you can show measures mapped to MP:0002062 only.

MP:0001454 abnormal cued conditioning behavior
MP:0001469 abnormal contextual conditioning behavior
MP:0002798 abnormal active avoidance behavior
MP:0002799 abnormal passive avoidance behavior
MP:0002803 abnormal operant conditioning behavior
MP:0009711 abnormal conditioned place preference behavior
MP:0020899 abnormal cocaine conditioned locomotor activation

This MP term has been mapped to these MPD phenotype measurements to help users find relevant data. It should be noted that MPD measurements typically have a mixture of high-end, low-end and "normal" readings.

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year

Bolivar2:1	Bolivar2	fear conditioning test	(none)	activity (beam breaks) during 2.5 min period of training on day 1 [n] act_shock 63901 before shock after 1st shock after 2nd shock after 3rd shock	inbred	8	both	9-20wks	N=18	2001

Bolivar2:5	Bolivar2	fear conditioning test	(none)	percentage of baseline activity that occurred after third shock of training period [%] act_shock3_pct 63905	inbred	8	both	9-20wks	N=18	2001

Bolivar2:6	Bolivar2	fear conditioning test	(none)	activity (beam breaks) during 1 min period of contextual conditioning on day 2 [n] act_context 63906 1st min 2nd min 3rd min 4th min 5th min mean	inbred	8	both	9-20wks	N=18	2001

Bolivar2:12	Bolivar2	fear conditioning test	(none)	percentage of baseline activity that occurred after contextual conditioning [%] act_context_pct 63912	inbred	8	both	9-20wks	N=18	2001

Bolivar2:13	Bolivar2	fear conditioning test	(none)	activity (beam breaks) during 1 min period of altered context on day 2 [n] act_altered 63913 1st min 2nd min 3rd min mean	inbred	8	both	9-20wks	N=18	2001

Bolivar2:17	Bolivar2	fear conditioning test	(none)	activity (beam breaks) during 1 min period of cued conditioning on day 2 [n] act_cued 63917 1st min 2nd min 3rd min mean	inbred	8	both	9-20wks	N=18	2001

Bolivar2:21	Bolivar2	fear conditioning test	(none)	percentage of altered context activity that occurred after cued conditioning [%] act_cued_pct 63921	inbred	8	both	9-20wks	N=18	2001

CSNA02:6	CSNA02	operant conditioning chamber	(none)	total number of trials in reversal learning needed to meet criteria [n] trials 62206 acquisition reversal	inbred	10	both	12-14wks	N=5	2018

CSNA02:8	CSNA02	operant conditioning chamber	(none)	number of anticipatory nose pokes made in correct flanking hole during reversal learning [n] pokes_corr 62208 acquisition reversal	inbred	10	both	12-14wks	N=5	2018

CSNA02:10	CSNA02	operant conditioning chamber	(none)	number of anticipatory nose pokes made in incorrect flanking hole during reversal learning [n] pokes_incorr 62210 acquisition reversal	inbred	10	both	12-14wks	N=5	2018

CSNA02:12	CSNA02	operant conditioning chamber	(none)	omissions during reversal learning divided by total number of trials [n] omits 62212 acquisition reversal	inbred	10	both	12-14wks	N=5	2018

CSNA02:14	CSNA02	operant conditioning chamber	(none)	latency to initiate trials divided by total number of trials [s] trial_latency 62214 acquisition reversal	inbred	10	both	12-14wks	N=5	2018

CSNA02:16	CSNA02	operant conditioning chamber	(none)	latency to receive Boost divided by total number of trials [s] reward_latency 62216 acquisition reversal	inbred	10	both	12-14wks	N=5	2018

CSNA02:18	CSNA02	operant conditioning chamber	(none)	scaling factor (k-value) for delay discounting (impulsive choice) scaling_factor 62218	inbred	10	both	12-14wks	N=5	2018

CSNA02:19	CSNA02	operant conditioning chamber	(none)	side bias (b-value) for delay discounting (impulsive choice) side_bias 62219	inbred	10	both	12-14wks	N=5	2018

CSNA03:319	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 12 (saline) minus Day 2 (saline), cocaine sensitization, founders [cm] dist_d12_d2_cocaine_in 90319	inbred w/CC8	10	both	8-14wks	N=6	2018

CSNA03:320	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 12 (saline) minus Day 2 (saline), cocaine sensitization, CC [cm] dist_d12_d2_cocaine_cc 90320	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:321	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 12 (saline) minus Day 2 (saline), cocaine sensitization, DO [cm] dist_d12_d2_cocaine_do 90321	DO population w/par	9	both	8-21wks	N=27	2018

CSNA03:449	CSNA03	operant conditioning chamber	cocaine	number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), founders [n] acquisition_in 110188	inbred w/CC8	7	both	4-25wks	N=10	2018

CSNA03:450	CSNA03	operant conditioning chamber	cocaine	number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), CC [n] acquisition_cc 110390	CC w/par	53	both	4-25wks	N=4	2018

CSNA03:451	CSNA03	operant conditioning chamber	cocaine	number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), DO [n] acquisition_do 110261	DO population w/par	8	both	4-25wks	N=48	2018

CSNA03:452	CSNA03	operant conditioning chamber	cocaine	dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, founders [n] infusions_in 110189 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)	inbred w/CC8	8	both	4-25wks	N=14	2018

CSNA03:461	CSNA03	operant conditioning chamber	cocaine	dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, CC [n] infusions_cc 110391 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)	CC w/par	57	both	4-25wks	N=6	2018

CSNA03:470	CSNA03	operant conditioning chamber	cocaine	dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, DO [n] infusions_do 110262 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)	DO population w/par	9	both	4-25wks	N=73	2018

CSNA03:479	CSNA03	operant conditioning chamber	cocaine	extinction, active lever presses (intravenous self administration), founders [n] extinction_active_in 110198 session: 1 2 3 4 5 6 7 8 9	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:488	CSNA03	operant conditioning chamber	cocaine	extinction, active lever presses (intravenous self administration), CC [n] extinction_active_cc 110400 session: 1 2 3 4 5 6 7 8 9	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:497	CSNA03	operant conditioning chamber	cocaine	extinction, active lever presses (intravenous self administration), DO [n] extinction_active_do 110271 session: 1 2 3 4 5 6 7 8 9	DO population w/par	8	both	4-25wks	N=39	2018

CSNA03:506	CSNA03	operant conditioning chamber	cocaine	extinction, inactive lever presses (intravenous self administration), founders [n] extinction_inactive_in 110207 session: 1 2 3 4 5 6 7 8 9	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:515	CSNA03	operant conditioning chamber	cocaine	extinction, inactive lever presses (intravenous self administration), CC [n] extinction_inactive_cc 110409 session: 1 2 3 4 5 6 7 8 9	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:524	CSNA03	operant conditioning chamber	cocaine	extinction, inactive lever presses (intravenous self administration), DO [n] extinction_inactive_do 110280 session: 1 2 3 4 5 6 7 8 9	DO population w/par	8	both	4-25wks	N=39	2018

CSNA03:533	CSNA03	operant conditioning chamber	cocaine	reinstatement, active lever presses (intravenous self administration), founders [n] reinstatement_active_in 110216 session: 1 2	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:535	CSNA03	operant conditioning chamber	cocaine	reinstatement, active lever presses (intravenous self administration), CC [n] reinstatement_active_cc 110418 session: 1 2	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:537	CSNA03	operant conditioning chamber	cocaine	reinstatement, active lever presses (intravenous self administration), DO [n] reinstatement_active_do 110289 session: 1 2 3	DO population w/par	8	both	4-25wks	N=42	2018

CSNA03:540	CSNA03	operant conditioning chamber	cocaine	reinstatement, inactive lever presses (intravenous self administration), founders [n] reinstatement_inactive_in 110218 session: 1 2	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:542	CSNA03	operant conditioning chamber	cocaine	reinstatement, inactive lever presses (intravenous self administration), CC [n] reinstatement_inactive_cc 110420 session: 1 2	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:544	CSNA03	operant conditioning chamber	cocaine	reinstatement, inactive lever presses (intravenous self administration), DO [n] reinstatement_inactive_do 110292 session: 1 2 3	DO population w/par	8	both	4-25wks	N=42	2018

CSNA03:547	CSNA03	operant conditioning chamber	cocaine	reinstatement, number of infusions (intravenous self administration), founders [n] reinstatement_inf_in 110220 session: 1 2	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:549	CSNA03	operant conditioning chamber	cocaine	reinstatement, number of infusions (intravenous self administration), CC [n] reinstatement_inf_cc 110422 session: 1 2	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:551	CSNA03	operant conditioning chamber	cocaine	reinstatement, number of infusions (intravenous self administration), DO [n] reinstatement_inf_do 110295 session: 1 2 3	DO population w/par	8	both	4-25wks	N=42	2018

CSNA03:554	CSNA03	operant conditioning chamber	(none)	number of days to meet criteria, (reversal learning assay), founders [n] days_criteria_in_JAX 110457 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:556	CSNA03	operant conditioning chamber	(none)	number of days to meet criteria, (reversal learning assay), CC [n] days_criteria_cc_JAX 110487 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:558	CSNA03	operant conditioning chamber	(none)	number of days to meet criteria, (reversal learning assay), DO [n] days_criteria_do_JAX 110517 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:560	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), founders [n] trials_in_JAX 110459 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:562	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), CC [n] trials_cc_JAX 110489 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:564	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), DO [n] trials_do_JAX 110519 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:566	CSNA03	operant conditioning chamber	(none)	reversal trials minus acquisition trials (reversal learning assay), founders [n] diff_trials_rev_acq_in_JAX 113850	inbred w/CC8	8	both		N=7	2021

CSNA03:567	CSNA03	operant conditioning chamber	(none)	reversal trials minus acquisition trials (reversal learning assay), CC [n] diff_trials_rev_acq_cc_JAX 113851	CC w/par	52	both		N=3	2021

CSNA03:568	CSNA03	operant conditioning chamber	(none)	reversal trials minus acquisition trials (reversal learning assay), DO [n] diff_trials_rev_acq_do_JAX 113853	DO population w/par	9	both		N=28	2021

CSNA03:569	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders [n] correct_in_JAX 110461 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:571	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC [n] correct_cc_JAX 110491 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:573	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), DO [n] correct_do_JAX 110521 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:575	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), founders [n] omit_in_JAX 110463 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:577	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC [n] omit_cc_JAX 110493 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:579	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), DO [n] omit_do_JAX 110523 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:581	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), founders [%] pct_correct_in_JAX 110465 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:583	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), CC [%] pct_correct_cc_JAX 110495 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:585	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), DO [%] pct_correct_do_JAX 110525 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:587	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), founders [%] pct_omit_in_JAX 110467 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:589	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), CC [%] pct_omit_cc_JAX 110497 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:591	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), DO [%] pct_omit_do_JAX 110527 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:593	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), founders [min] total_time_in_JAX 110469 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:595	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), CC [min] total_time_cc_JAX 110499 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:597	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), DO [min] total_time_do_JAX 110529 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:605	CSNA03	operant conditioning chamber	(none)	mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders [centiseconds/n] trial_init_latency_in_JAX 110473 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:607	CSNA03	operant conditioning chamber	(none)	mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), CC [centiseconds/n] trial_init_latency_cc_JAX 110503 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:609	CSNA03	operant conditioning chamber	(none)	mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), DO [centiseconds/n] trial_init_latency_do_JAX 110533 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:617	CSNA03	operant conditioning chamber	(none)	latency to retrieve reward per total correct responses (reversal learning assay), founders [centiseconds/n] reward_time_in_JAX 110477 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:619	CSNA03	operant conditioning chamber	(none)	latency to retrieve reward per total correct responses (reversal learning assay), CC [centiseconds/n] reward_time_cc_JAX 110507 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:621	CSNA03	operant conditioning chamber	(none)	latency to retrieve reward per total correct responses (reversal learning assay), DO [centiseconds/n] reward_time_do_JAX 110537 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:623	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_resp_left_in_JAX 110479 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:625	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_resp_left_cc_JAX 110509 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:627	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_resp_left_do_JAX 110539 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:629	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_resp_right_in_JAX 110481 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:631	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_resp_right_cc_JAX 110511 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:633	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_resp_right_do_JAX 110541 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:635	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_correct_in_JAX 110483 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:637	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_correct_cc_JAX 110513 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:639	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_correct_do_JAX 110543 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:641	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_incorrect_in_JAX 110485 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:643	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_incorrect_cc_JAX 110515 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:645	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_incorrect_do_JAX 110545 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:647	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), founders [n] trials_in_Binghamton 112873 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:649	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), CC [n] trials_cc_Binghamton 112891 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:651	CSNA03	operant conditioning chamber	(none)	reversal trials minus acquisition trials (reversal learning assay), founders [n] diff_trials_rev_acq_in_Binghamton 113852	inbred w/CC8	8	both		N=5	2021

CSNA03:652	CSNA03	operant conditioning chamber	(none)	reversal trials minus acquisition trials (reversal learning assay), CC [n] diff_trials_rev_acq_cc_Binghamton 113854	CC w/par	18	both		N=4	2021

CSNA03:653	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders [n] correct_in_Binghamton 112875 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:655	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC [n] correct_cc_Binghamton 112893 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:657	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), founders [n] omit_in_Binghamton 112877 acquisition reversal	inbred w/CC8	8	both		N=5	2021

CSNA03:659	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC [n] omit_cc_Binghamton 112895 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:661	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), founders [%] pct_correct_in_Binghamton 112879 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:663	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), CC [%] pct_correct_cc_Binghamton 112897 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:665	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), founders [%] pct_omit_in_Binghamton 112881 acquisition reversal	inbred w/CC8	8	both		N=5	2021

CSNA03:667	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), CC [%] pct_omit_cc_Binghamton 112899 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:669	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), founders [min] total_time_in_Binghamton 112883 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:671	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), CC [min] total_time_cc_Binghamton 112901 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:673	CSNA03	operant conditioning chamber	(none)	mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders [centiseconds/n] trial_init_latency_in_Binghamton 112885 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:675	CSNA03	operant conditioning chamber	(none)	mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), CC [centiseconds/n] trial_init_latency_cc_Binghamton 112903 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:677	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_correct_in_Binghamton 112887 acquisition reversal	inbred w/CC8	8	both		N=5	2021

CSNA03:679	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_correct_cc_Binghamton 112905 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:681	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_incorrect_in_Binghamton 112889 acquisition reversal	inbred w/CC8	8	both		N=5	2021

CSNA03:683	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_incorrect_cc_Binghamton 112907 acquisition reversal	CC w/par	18	both		N=4	2021

Dickson1:1	Dickson1	operant conditioning chamber	(none)	goal-tracking [s] GTdur_all 54601 unpaired paired	inbred	5	both	12-20wks	N=5	2015

Dickson1:11	Dickson1	operant conditioning chamber	(none)	sign-tracking [s] STdur_all 54611 unpaired paired	inbred	5	both	12-20wks	N=5	2015

Dickson2:31	Dickson2	operant conditioning chamber	cocaine	intravenous self-administration, mean number of infusions (fixed ratio 1 (FR1) schedule), over ten 120 min sessions [n] FR1_infusions_mean 54831	DO population		both	12-16wks	N=35	2015

Dickson2:32	Dickson2	operant conditioning chamber	cocaine	intravenous self-administration, mean number of responses on the active lever (fixed ratio 1 (FR1) schedule), over ten 120 min sessions [n] FR1_active_mean 54832	DO population		both	12-16wks	N=35	2015

Dickson2:33	Dickson2	operant conditioning chamber	cocaine	intravenous self-administration, mean number of responses on the inactive lever (fixed ratio 1 (FR1) schedule), over ten 120 min sessions [n] FR1_inactive_mean 54833	DO population		both	12-16wks	N=35	2015

Dickson2:41	Dickson2	operant conditioning chamber	cocaine	intravenous self-administration, breakpoint for infusions (progressive ratio (PR) schedule), one 6h test [n] PR_infusions_breakpoint 54841	DO population		both	12-16wks	N=31	2015

Dickson2:42	Dickson2	operant conditioning chamber	cocaine	intravenous self-administration, number of presses on the active lever (progressive ratio (PR) schedule), one 6h test [n] PR_active 54842	DO population		both	12-16wks	N=31	2015

Dickson2:43	Dickson2	operant conditioning chamber	cocaine	intravenous self-administration, number of presses on the inactive lever (progressive ratio (PR) schedule), one 6h test [n] PR_inactive 54843	DO population		both	12-16wks	N=31	2015

Gould2:17	Gould2	fear conditioning test	nicotine	acute group, percent immobility in training chamber after first stimulus pairing [%] FC_immediate_acu 47131 dose (mg): control 0.045 0.09 0.18	inbred	8	m	8-12wks	N=11	2011

Gould2:21	Gould2	fear conditioning test	nicotine	acute group, percent immobility in training chamber, 24h after fear conditioning [%] FC_context_acu 47136 dose (mg): control 0.045 0.09 0.18	inbred	8	m	8-12wks	N=11	2011

Gould2:29	Gould2	fear conditioning test	nicotine	acute group, percent immobility in altered context chamber, cue [%] FC_CS_acu 47146 dose (mg) control 0.045 0.09 0.18	inbred	8	m	8-12wks	N=11	2011

Gould2:33	Gould2	fear conditioning test	nicotine	chronic group, conditioning: immediate fear [%] FC_immediate_chr 47151 control nicotine	inbred	8	m	8-12wks	N=10	2011

Gould2:35	Gould2	fear conditioning test	nicotine	chronic group, conditioning: contextual fear [%] FC_context_chr 47156 control nicotine	inbred	8	m	8-12wks	N=10	2011

Gould2:39	Gould2	fear conditioning test	nicotine	chronic group, cued fear: cue [%] FC_CS_chr 47166 control nicotine	inbred	8	m	8-12wks	N=10	2011

Gould3:41	Gould3	fear conditioning test	nicotine	withdrawal study group, percent immobility in training chamber after first stimulus pairing [%] FC_immediate 47341 control nicotine dose (mg) 3 6.3 12	inbred	8	m	8-12wks	N=12	2011

Gould3:46	Gould3	fear conditioning test	nicotine	withdrawal study group, percent immobility in training chamber, 24h after fear conditioning [%] FC_context 47346 control nicotine dose (mg) 3 6.3 12	inbred	8	m	8-12wks	N=12	2011

Gould3:66	Gould3	fear conditioning test	nicotine	withdrawal study group, percent immobility in altered context chamber, cue [%] FC_CS 47366 control nicotine dose (mg) 3 6.3 12	inbred	8	m	8-12wks	N=12	2011

Gould4:1	Gould4	conditioned place preference test	nicotine	conditioned place preference score for test 1 [s] pref_score1 54701 control nicotine	inbred	8	m	8-10wks	N=9	2014

Gould4:11	Gould4	conditioned place preference test	nicotine	conditioned place preference score for test 2 [s] pref_score2 54711 control nicotine	inbred	8	m	8-10wks	N=9	2014

HMDPpheno4:1	HMDPpheno4	fear conditioning test	(none)	fear training, percent time spent near chamber walls, day1 [%] ftr_thig 46801 pre-stimulus post-stimulus	HMDP w/par	94	m	10wks	N=7	2011

HMDPpheno4:11	HMDPpheno4	fear conditioning test	(none)	fear training, velocity, day 1 [cm/s] ftr_vel 46811 pre-stimulus post-stimulus	HMDP w/par	94	m	10wks	N=7	2011

HMDPpheno4:21	HMDPpheno4	fear conditioning test	(none)	fear training, percent time immobile, day 1 [%] ftr_imob 46821 pre-stimulus post-stimulus	HMDP w/par	94	m	10wks	N=7	2011

HMDPpheno4:31	HMDPpheno4	fear conditioning test	(none)	fear training activity burst to footshock, shock reactivity, day 1 [cm/s] ftr_post_act_burst 46831	HMDP w/par	94	m	10wks	N=7	2011

HMDPpheno4:36	HMDPpheno4	fear conditioning test	(none)	contextual fear thigmotaxis, percent time spent near chamber walls, day 2 [%] ctx_thig 46836	HMDP w/par	94	m	10wks	N=7	2011

HMDPpheno4:41	HMDPpheno4	fear conditioning test	(none)	contextual fear velocity, day 2 [cm/s] ctx_vel 46841	HMDP w/par	94	m	10wks	N=7	2011

HMDPpheno4:46	HMDPpheno4	fear conditioning test	(none)	contextual fear percent time immobile, day 2 [%] ctx_imob 46846	HMDP w/par	94	m	10wks	N=7	2011

Jentsch1:1	Jentsch1	operant conditioning chamber	(none)	number of initiated trials per daily session, acquisition phase [n] acq_initiated_trials 40301	BXD w/par	53	m	17wks	N=3	2011

Jentsch1:2	Jentsch1	operant conditioning chamber	(none)	number of trials with no choice made in first 30 s, acquisition phase [n] acq_no_choice 40302	BXD w/par	53	m	17wks	N=3	2011

Jentsch1:3	Jentsch1	operant conditioning chamber	(none)	average number of anticipatory responses per trial, acquisition phase [n] acq_anticipatory 40303	BXD w/par	53	m	17wks	N=3	2011

Jentsch1:4	Jentsch1	operant conditioning chamber	(none)	average latency to initiate trial, acquisition phase [s] acq_latency_trial 40304	BXD w/par	53	m	17wks	N=3	2011

Jentsch1:5	Jentsch1	operant conditioning chamber	(none)	average latency to make correct choice, acquisition phase [s] acq_latency_correct 40305	BXD w/par	53	m	17wks	N=3	2011

Jentsch1:6	Jentsch1	operant conditioning chamber	(none)	average latency to retrieve food reward, acquisition phase [s] acq_latency_reward 40306	BXD w/par	53	m	17wks	N=3	2011

Jentsch1:7	Jentsch1	operant conditioning chamber	(none)	number of initiated trials per daily session, reversal phase [n] revers_init_trials 40307	BXD w/par	53	m	17wks	N=3	2011

Jentsch1:8	Jentsch1	operant conditioning chamber	(none)	number of trials with no choice made in first 30 s, reversal phase [n] revers_no_choice 40308	BXD w/par	53	m	17wks	N=3	2011

Jentsch1:9	Jentsch1	operant conditioning chamber	(none)	average number of anticipatory responses per trial, reversal phase [n] revers_anticipatory 40309	BXD w/par	53	m	17wks	N=3	2011

Jentsch1:10	Jentsch1	operant conditioning chamber	(none)	average latency to initiate trial, reversal phase [s] revers_latency_trial 40310	BXD w/par	53	m	17wks	N=3	2011

Jentsch1:11	Jentsch1	operant conditioning chamber	(none)	average latency to make correct choice, reversal phase [s] revers_latency_correct 40311	BXD w/par	53	m	17wks	N=3	2011

Jentsch1:12	Jentsch1	operant conditioning chamber	(none)	average latency to retrieve food reward, reversal phase [s] revers_latency_reward 40312	BXD w/par	53	m	17wks	N=3	2011

Jentsch2:1	Jentsch2	operant conditioning chamber	cocaine	number of sessions (days) required to reach criteria for self-administration (FR1 reinforcement schedule) [d] acquisition_FR1 49701	BXD	4	both	8-17wks	N=8	2013

Jentsch2:2	Jentsch2	operant conditioning chamber	cocaine	Fixed ratio 1 - self administration: number of infusions earned [n] infusions_FR1 49702 day 1 day 3 day 5 last day	BXD	4	both	8-17wks	N=8	2013

Jentsch2:6	Jentsch2	operant conditioning chamber	cocaine	Fixed ratio 1 - discrimination index between active and inactive levers [%] discrimination_FR1 49706 day 1 day 3 day 5 last day	BXD	4	both	8-17wks	N=7	2013

Jentsch2:10	Jentsch2	operant conditioning chamber	cocaine	Fixed ratio 1 - time-out: number of responses [n] timeout_FR1 49710 day 1 day 3 day 5 last day	BXD	4	both	8-17wks	N=7	2013

Jentsch2:14	Jentsch2	operant conditioning chamber	cocaine	Fixed ratio 2 - self administration: number of infusions earned [n] infusions_FR2 49714 day 1 day 2 day 4	BXD	4	both	8-17wks	N=6	2013

Jentsch2:17	Jentsch2	operant conditioning chamber	cocaine	Fixed ratio 2 - discrimination index between active and inactive levers [%] discrimination_FR2 49717 day 1 day 2 day 4	BXD	4	both	8-17wks	N=6	2013

Jentsch2:20	Jentsch2	operant conditioning chamber	cocaine	Fixed ratio 2 - time-out: number of responses [n] timeout_FR2 49720 day 1 day 2 day 4	BXD	4	both	8-17wks	N=6	2013

Jentsch2:23	Jentsch2	operant conditioning chamber	cocaine	Fixed ratio 5 - self administration: number of infusions earned [n] infusions_FR5 49723 day 1 day 3 day 5	BXD	4	both	8-17wks	N=6	2013

Jentsch2:26	Jentsch2	operant conditioning chamber	cocaine	Fixed ratio 5 - discrimination index between active and inactive levers [%] discrimination_FR5 49726 day 1 day 3 day 5	BXD	4	both	8-17wks	N=6	2013

Jentsch2:29	Jentsch2	operant conditioning chamber	cocaine	Fixed ratio 5 - time-out: number of responses [n] timeout_FR5 49729 day 1 day 3 day 5	BXD	4	both	8-17wks	N=6	2013

Koide1:5	Koide1	avoidance test	(none)	passive avoidance test: latency to enter box before stimulus [s] PA_BEFORE 1805	wild-derived Mishima	11	f	8-13wks	N=10	2000

Koide1:6	Koide1	avoidance test	(none)	passive avoidance test: latency to enter box after stimulus [s] PA_AFTER 1806	wild-derived Mishima	11	f	8-13wks	N=10	2000

Koide1:7	Koide1	avoidance test	(none)	passive avoidance test: learned fear response, latency to enter box next day [s] PA_LEARNED 1807	wild-derived Mishima	11	f	8-13wks	N=10	2000

Koide1:11	Koide1	avoidance test	(none)	active avoidance test: correct responses [%] AA 1811 day1 day2 day3 day4	wild-derived Mishima	10	f	8-13wks	N=10	2000

Mitchell1:3	Mitchell1	go/no-go task	(none)	number of responses made during pre-cue period [n/s] precue_rate 37603	inbred	15	m	5-7wks	N=8	2010

Mitchell1:4	Mitchell1	go/no-go task	(none)	ratio of Go trials with responses [ratio] go_response 37604	inbred	15	m	5-7wks	N=8	2010

Mitchell1:5	Mitchell1	go/no-go task	(none)	ratio of No-go trials with responses (false alarms) [ratio] nogo_response 37605	inbred	15	m	5-7wks	N=8	2010

Mitchell1:6	Mitchell1	go/no-go task	(none)	latency to respond to Go cue [s] go_latency 37606	inbred	15	m	5-7wks	N=8	2010

Mitchell1:7	Mitchell1	go/no-go task	(none)	latency to respond to No-go cue [s] nogo_latency 37607	inbred	15	m	5-7wks	N=8	2010

Mitchell1:8	Mitchell1	go/no-go task	(none)	ratio of responses that occurred in the target location [ratio] target_specific 37608	inbred	15	m	5-7wks	N=8	2010

Mitchell1:9	Mitchell1	go/no-go task	(none)	number of rewards per total number of responses [ratio] efficiency 37609	inbred	15	m	5-7wks	N=8	2010

Mitchell1:10	Mitchell1	go/no-go task	(none)	index of discrimination of Go versus No-go cues [ratio] discrim_index 37610	inbred	15	m	5-7wks	N=8	2010

Neuner1:62	Neuner1	fear conditioning test	(none)	percentage of time spent freezing during 40 s interval post shock at 6 mo of age, day 1 contextual fear conditioning [%] cfc_6mo 65962 baseline 1st shock 2nd shock 3rd shock 4th shock	F1 AD-BXD	50	both	23-25wks	N=3	2019

Neuner1:67	Neuner1	fear conditioning test	(none)	percentage of time spent freezing during 40 s interval post shock at 14 mo of age, day 1 contextual fear conditioning [%] cfc_14mo 65967 baseline 1st shock 2nd shock 3rd shock 4th shock	F1 AD-BXD	51	both	55-57wks	N=4	2019

Neuner1:72	Neuner1	fear conditioning test	(none)	change in percentage of time spent freezing from 1st post-shock to 4th post-shock (slope), day 1 contextual fear acquisition cfa_change 65972 6 mo 14 mo	F1 AD-BXD	55	both	23-57wks	N=3	2019

Neuner1:74	Neuner1	fear conditioning test	(none)	percentage of time spent freezing at 6 mo of age, day 2 contextual fear memory, 10 min test [%] cfm_6mo 65974 1st 2 min 2nd 2 min 3rd 2 min 4th 2 min 5th 2 min total	F1 AD-BXD	50	both	23-25wks	N=3	2019

Neuner1:80	Neuner1	fear conditioning test	(none)	percentage of time spent freezing at 14 mo of age, day 2 contextual fear memory, 10 min test [%] cfm_14mo 65980 1st 2 min 2nd 2 min 3rd 2 min 4th 2 min 5th 2 min total	F1 AD-BXD	51	both	55-57wks	N=4	2019

Palmer1:3	Palmer1	fear conditioning test	(none)	time freezing in context with 24h history and exposure to shock, from 30-180s, day 2 [s] freezing_to_context 25503	B6.A consomic w/par	19	both	7-12wks	N=12	2007

Palmer1:4	Palmer1	fear conditioning test	(none)	time freezing in altered context (no tone) with 48h history and exposure to shock, from 30-180s, day 3 [s] freezing_altered 25504	B6.A consomic w/par	19	both	7-12wks	N=12	2007

Palmer1:5	Palmer1	fear conditioning test	(none)	time freezing in altered context during 30 s in between 2 tones, day 3 [s] freezing_btw_tones 25505	B6.A consomic w/par	19	both	7-12wks	N=12	2007

Palmer1:6	Palmer1	fear conditioning test	(none)	average time freezing during two 30 s tones in altered context, day 3 [s] freezing_to_tones 25506	B6.A consomic w/par	19	both	7-12wks	N=12	2007

Palmer3:21	Palmer3	fear conditioning test	(none)	percentage of time freezing during tone presentation on day 1 [%] d1_tone 59221	F1 Tcf7l2	30	both	7-14wks	N=5	2017

Palmer3:22	Palmer3	fear conditioning test	(none)	percentage of time freezing to context on day 2 [%] d2_context 59222	F1 Tcf7l2	30	both	7-14wks	N=5	2017

Palmer3:23	Palmer3	fear conditioning test	(none)	percentage of time freezing to tone on day 3 [%] d3_tone 59223	F1 Tcf7l2	30	both	7-14wks	N=5	2017

Palmer5:21	Palmer5	fear conditioning test	(none)	percentage of time freezing during tone presentation on day 1 [%] d1_tone 59721	F1 Tcf7l2	30	both	7-14wks	N=5	2017

Palmer5:22	Palmer5	fear conditioning test	(none)	percentage of time freezing to context on day 2 [%] d2_context 59722	F1 Tcf7l2	30	both	7-14wks	N=5	2017

Palmer5:23	Palmer5	fear conditioning test	(none)	percentage of time freezing to tone on day 3 [%] d3_tone 59723	F1 Tcf7l2	30	both	7-14wks	N=5	2017

Schalkwyk1:18	Schalkwyk1	puzzle box	(none)	latency to reach goal during training, 3 min test [s] laten_goal_PBtrain 34518	inbred	8	m	9-11wks	N=11	2010

Schalkwyk1:19	Schalkwyk1	puzzle box	(none)	latency to reach goal during burrowing task, 3 min test [s] laten_goal_PBbur 34519	inbred	8	m	9-11wks	N=11	2010

Schalkwyk1:20	Schalkwyk1	puzzle box	(none)	latency to reach goal during plug task, 3 min test [s] laten_goal_PBplug 34520	inbred	8	m	9-11wks	N=11	2010

Shin1:1	Shin1	observational fear learning test	(none)	percent time freezing during 4 min of conditioning (empathic fear) [%] OFL_conditioning 54501	inbred	11	m	12-14wks	N=13	2016

Shin1:2	Shin1	observational fear learning test	(none)	percent time freezing during 4 min of contextual exposure (empathic fear) [%] OFL_memory 54502	inbred	11	m	12-14wks	N=13	2016

Shin1:3	Shin1	fear conditioning test	(none)	percent time freezing during 5 min of contextual exposure [%] FC_memory 54503	inbred	11	m	12-14wks	N=10	2016

Spijker1:19	Spijker1	choice serial reaction time task	(none)	percentage of total Reponses that are correct, stimulus duration fixed, 1s [%] accuracy_SD1 40619	BXD w/par	43	m	8wks	N=13	2011

Spijker1:20	Spijker1	choice serial reaction time task	(none)	percentage of events that are omission errors, stimulus duration fixed, 1s [%] omission_SD1 40620	BXD w/par	43	m	8wks	N=13	2011

Spijker1:21	Spijker1	choice serial reaction time task	(none)	correct response latency, stimulus duration fixed, 1s [s] latency_correct 40621	BXD w/par	43	m	8wks	N=13	2011

Spijker1:22	Spijker1	choice serial reaction time task	(none)	mode of correct response latencies, stimulus duration fixed, 1s [s] latency_mode 40622	BXD w/par	43	m	8wks	N=13	2011

Spijker1:23	Spijker1	choice serial reaction time task	(none)	individual variability of correct response latency [s] variability_SD1 40623	BXD w/par	43	m	8wks	N=13	2011

Spijker1:24	Spijker1	choice serial reaction time task	(none)	latency between correct response and head entry detected in food magazine, stimulus duration fixed, 1s [s] latency_reward 40624	BXD w/par	43	m	8wks	N=13	2011

Spijker1:25	Spijker1	choice serial reaction time task	(none)	number of initiated trials, stimulus duration 1s [n] trials_initiated 40625	BXD w/par	43	m	8wks	N=13	2011

Spijker1:26	Spijker1	choice serial reaction time task	(none)	percentage of total responses that are correct, stimulus duration variable [%] accuracy_SDvar 40626	BXD w/par	43	m	8wks	N=13	2011

Spijker1:27	Spijker1	choice serial reaction time task	(none)	percentage of events that are omission errors, stimulus duration variable [%] omission_SDvar 40627	BXD w/par	43	m	8wks	N=13	2011

Spijker2:27	Spijker2	choice serial reaction time task	(none)	anticipatory magazine response, 25 min test [n] magazine_resp 44027	inbred	12	m	6wks	N=12	2009

Spijker2:28	Spijker2	choice serial reaction time task	(none)	latency to collect food from magazine, 25 min test [s] lat_food 44028	inbred	12	m	6wks	N=12	2009

Spijker2:29	Spijker2	choice serial reaction time task	(none)	impulsivity, 25 min test [%] impulsivity 44029	inbred	12	m	6wks	N=12	2009

All boxes To see more rows use the paging control at top.

Filter Table Results